A Conversation on the Chronic Urticaria Landscape

Executed on:Jan 4, 2022 12:00 PM EDT

Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert

Institution: University of Rochester

Professor of Dermatology, Professor of Medicine (AIR) and Pathology & Laboratory Medicine at University of Rochester Medical Center.
Manages 500 patients with atopic dermatitis (60% Pediatric) and 30 patients per month with chronic urticaria.
Research was instrumental in the development of dupilumab (Dupixent); Lead author of a 2014 NEJM paper that set the stage for the FDA approval of Dupixent.

Interview Goal

Learn more on the views about the current urticaria treatment landscape

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.